Profil
Finn M.
Ulrich joined Millimed A/S in September 2004 and currently serves as Vice President of Research and Development.
Previously, he was Director of Medical Device Operations for Novo Nordisk A/S from 1996 to 2001 and Project Director of Research and Development from 2001 to 2004.
Before joining Novo Nordisk, Mr. Ulrich was Engineer of Research and Development for Brüel & Kjær A/S from 1986 to 1991.
He has research and development, manufacturing, quality assurance, and pharmaceutical engineering in the medtech industry.
Mr. Ulrich received a Bachelor of Commerce degree from the Copenhagen Business School Finn and a Master of Science degree in Electronical Engineering from the Technical University of Denmark.
Ehemalige bekannte Positionen von Finn M. Ulrich
Unternehmen | Position | Ende |
---|---|---|
Millimed A/S
Millimed A/S Medical/Nursing ServicesHealth Services Millimed A/S develops treatment solutions for vascular disease. The company also develops next generation alternatives for site specific drug and agent elution. It provides electro-spinning programs to support regeneration of vessels in diseased and abnormal vasculature. Millimed was founded in May 2004 and is headquartered in Roskilde, Denmark | Technik-/Wissenschafts-/F&E-Leiter | 25.06.2009 |
NOVO NORDISK A/S | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NOVO NORDISK A/S | Health Technology |
Private Unternehmen | 1 |
---|---|
Millimed A/S
Millimed A/S Medical/Nursing ServicesHealth Services Millimed A/S develops treatment solutions for vascular disease. The company also develops next generation alternatives for site specific drug and agent elution. It provides electro-spinning programs to support regeneration of vessels in diseased and abnormal vasculature. Millimed was founded in May 2004 and is headquartered in Roskilde, Denmark | Health Services |